In NB, this has been explained by stress-regulated alternative TrkAIII splicing that can convert tumour-suppressing signals from fully spliced TrkA into oncogenic signals from the alternative TrkAIII splice variant [14,15], as an alternative oncogenic mechanism to NTRK1 amplification and chimeric TrkA fusion. The gene discussed is NTRK1; the disease is neuroblastoma.